SPASMOLYTIC DRUG NORMALIZING INTESTINAL MOTILITY FOR VETERINARY SCIENCE Russian patent published in 2024 - IPC A61K31/235 A61K31/24 A61K9/00 A61K9/08 A61P1/00 A61P1/06 

FIELD: veterinary science.

SUBSTANCE: invention refers to veterinary science, namely to drugs eliminating spastic contractions of intestinal smooth muscles and normalizing gastrointestinal motility in animals. Disclosed is the use of an oral drug in a liquid dosage form in the form of a solution containing mebeverine hydrochloride as an active substance and auxiliary substances: a solvent or a combination of solvents, a viscosity modifier, a preservative, a pH regulator, for the therapy of intestinal disorders in animals, namely: in cats weighing 0.8–1.5 kg with a content of mebeverine hydrochloride in amount of 2 wt.%; in dogs with weight of 16–25 kg with content of mebeverine hydrochloride in amount of 4 wt.%; in large breeds of dogs weighing 40–55 kg with content of mebeverine hydrochloride in amount of 20 wt.%.

EFFECT: invention provides a wider range of veterinary drugs having antispasmodic action, convenient for dosage and application, free from side effects and contraindications, which increase the effectiveness of treatment and are suitable for long-term use.

1 cl, 4 tbl, 8 ex